ALARIS Medical Systems, Inc., (AMEX: AMI), develops practical solutions for medication safety. The Company designs, manufactures and markets intravenous (IV) medication delivery and infusion therapy devices, needle-free disposables and related monitoring equipment in the United States and internationally. ALARIS Medical System's proprietary Guardrails® Safety Software, its other "smart" technologies and its "smart" services help to reduce the risks and costs of medication errors, help to safeguard patients and clinicians and also gather and record clinical information for review, analysis and transcription. The Company provides its products, professional and technical support and training services to over 5,000 hospital and health care systems, as well as alternative care sites in more than 120 countries through its direct sales force and distributors.
Headquartered in San Diego, California, ALARIS Medical Systems employs approximately 2,900 people worldwide and operates manufacturing facilities in the United States, Mexico and the United Kingdom. The Company has two strategic business units: North America, which includes the U.S. and Canada, and International, which includes Europe, Asia, the Middle East, Latin America, Australia, New Zealand and South Africa.
The Company's sales to customers in the North America business unit and International business unit accounted for approximately 69% and 31%, respectively, of the Company's total sales for 2002. For the year ended December 31, 2002, the Company had sales of approximately $ 460.3 million.
ALARIS Medical Systems, Inc. was originally incorporated on September 28, 1988 under the name "Advanced Medical Technologies, Inc." The name "ALARIS Medical" was introduced in 1996 following the merger of two pioneers and leaders of infusion system technology, IMED Corporation and IVAC Medical Systems, Inc.